Vanguard Personalized Indexing Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$9.45 Billion
Q3 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 13, 2025	BUY	$1.59 - $3.24 $1,448 - $2,951	911 Added 5.67%	16,966 $26,000
Q4 2024 Feb 10, 2025	BUY	$2.7 - $4.03 $43,348 - $64,701	16,055 New	16,055 $48,000

Others Institutions Holding ZNTL

# of Institutions

120

Shares Held

60.4M

Call Options Held

Put Options Held

22K

Matrix Capital Management Company, LP Waltham, MA

14M
Shares

$18.4 Million
8.42% of portfolio
Black Rock Inc. New York, NY

4.82M
Shares

$6.36 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.48M
Shares

$4.59 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.88M
Shares

$3.81 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

2.8M
Shares

$3.69 Million
0.01% of portfolio

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $75.2M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account